{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:48:54Z","timestamp":1780516134265,"version":"3.54.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Longkui Yinxiao Soup is a traditional Chinese medicine formula used to treat psoriasis for decades. Although Longkui Yinxiao Soup showed promising efficacy in clinical practice, the regulatory mechanisms of Longkui Yinxiao Soup remain elusive. This study aimed to explore the underlying mechanisms of Longkui Yinxiao Soup in a psoriasis-like mouse model.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Longkui Yinxiao Soup was quality controlled by determining the contents of imperatorin and rhoifolin using high-performance liquid chromatography. The imiquimod-induced psoriasis-like mouse model was used to study the therapeutic effect and mechanism of Longkui Yinxiao Soup. The histopathological skin changes were observed by hematoxylin and eosin staining; the infiltration of proliferating proteins, proliferating cell nuclear antigen and Ki67, in skin tissues were observed by immunohistochemical analysis; and the inflammatory factors such as interleukin (IL)-6, tumor necrosis factor (TNF)-\u03b1, IL-23, and IL-17 in serum were detected using enzyme-linked immunosorbent assay. RNA sequencing and bioinformatic analysis were used to predict the mechanism of LYS against psoriasis. mRNA expressions of p38, extracellular regulated protein kinases (ERK), mitogen-activated protein kinase 3 (MEK3), mitogen-activated protein kinase 6 (MEK6), RAP1 GTPase activating protein (Rap1gap), and Rap1 were determined using real-time quantitative polymerase chain reaction. The expression levels of proteins related to Rap1\u2013mitogen-activated protein kinase signaling pathways were measured by Western blotting.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A quality-control method for Longkui Yinxiao Soup was successfully established using imperatorin and rhoifolin as content determination indexes. Longkui Yinxiao Soup significantly ameliorated the psoriatic symptoms in mice. The serum levels of inflammatory cytokines such as IL-6, TNF-\u03b1, IL-23, and IL-17 were decreased, and the expression levels of antigen identified by monoclonal antibody Ki67 (Ki67) and PCNA in skin tissues were downregulated. Moreover, the inhibition of Rap1\u2013MAPK signaling pathways by Longkui Yinxiao Soup was detected.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study confirmed the antipsoriatic activity of Longkui Yinxiao Soup in psoriasis-like mice. This might be due to the inhibition of inflammatory factor secretion, keratinocyte proliferation, and the Rap1\u2013MAPK signal pathway.<\/jats:p>","DOI":"10.3389\/fphar.2023.1136604","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T04:32:06Z","timestamp":1678681926000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect and mechanism of longkui yinxiao soup in treating psoriasis in mice"],"prefix":"10.3389","volume":"14","author":[{"given":"Congcong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongguang","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1684\/ejd.2018.3357","article-title":"Eosin treatment for psoriasis reduces skin leukocyte infiltration and secretion of inflammatory chemokines and angiogenic factors","volume":"28","author":"Capriotti","year":"2018","journal-title":"Eur. J. Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","article-title":"The inflammatory response in psoriasis: A comprehensive review","volume":"50","author":"Deng","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J. Invest. Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"155357","DOI":"10.1016\/j.cyto.2020.155357","article-title":"Synergistic induction of IL-23 by TNF\u03b1, IL-17A, and EGF in keratinocytes","volume":"138","author":"Ehst","year":"2021","journal-title":"Cytokine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s10753-020-01286-x","article-title":"Rhoifolin alleviates inflammation of acute inflammation animal models and LPS-induced RAW264.7 cells via IKK\u03b2\/NF-\u03baB signaling pathway","volume":"43","author":"Fang","year":"2020","journal-title":"Inflammation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12951-021-00842-3","article-title":"Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation","volume":"19","author":"Gangadevi","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"Griffiths","year":"2021","journal-title":"Psoriasis. Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3390\/ijms23042112","article-title":"Selenium-rich yeast peptide fraction ameliorates imiquimod-induced psoriasis-like dermatitis in mice by inhibiting inflammation via MAPK and NF-\u03baB signaling pathways","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cellsig.2009.11.008","article-title":"C3G down-regulates p38 MAPK activity in response to stress by rap-1 independent mechanisms: Involvement in cell death","volume":"22","author":"Guti\u00e9rrez-Uzquiza","year":"2010","journal-title":"Cell Signal"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.3390\/ijms19102848","article-title":"The many faces of Rap1 GTPase","volume":"19","author":"Ja\u015bkiewicz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2133.2004.06304.x","article-title":"The mitogen-activated protein kinases p38 and ERK1\/2 are increased in lesional psoriatic skin","volume":"152","author":"Johansen","year":"2005","journal-title":"Br. J. Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"941071","DOI":"10.3389\/fimmu.2022.941071","article-title":"Dendritic cells and macrophages in the pathogenesis of psoriasis","volume":"13","author":"Kamata","year":"2022","journal-title":"Front. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: What is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br. J. Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"632414","DOI":"10.3389\/fphar.2021.632414","article-title":"Transcriptomic analysis of the mechanisms for alleviating psoriatic dermatitis using taodan granules in an imiquimod-induced psoriasis-like mouse model","volume":"12","author":"Kuai","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/PTT.S327310","article-title":"Updated perspectives on keratinocytes and psoriasis: Keratinocytes are more than innocent bystanders","volume":"12","author":"Ortiz-Lopez","year":"2022","journal-title":"Psoriasis (Auckl)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1083\/jcb.148.6.1151","article-title":"The small GTPase, Rap1, mediates CD31-induced integrin adhesion","volume":"148","author":"Reedquist","year":"2000","journal-title":"J. Cell Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.4049\/jimmunol.0903162","article-title":"IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation","volume":"184","author":"Roussel","year":"2010","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2019.06.019","article-title":"Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis","volume":"144","author":"Sakurai","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/jdv.15762","article-title":"Incidence and prevalence of psoriasis in Israel between 2011 and 2017","volume":"33","author":"Schonmann","year":"2019","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/2589977513666210707114520","article-title":"IL-23\/Th17 Axis: A potential therapeutic target of psoriasis","volume":"14","author":"Sharma","year":"2022","journal-title":"Curr. Drug Res. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3389\/fimmu.2019.01865","article-title":"IL-21 induces an imbalance of Th17\/treg cells in moderate-to-severe plaque psoriasis patients","volume":"7","author":"Shi","year":"2019","journal-title":"Front. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1089\/ars.2019.7835","article-title":"Imperatorin alleviates psoriasiform dermatitis by blocking neutrophil respiratory burst, adhesion, and chemotaxis through selective phosphodiesterase 4 inhibition","volume":"35","author":"Tsai","year":"2021","journal-title":"Antioxid. Redox Signal"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1001\/jama.2022.5270","article-title":"Psoriasis","volume":"327","author":"Walter","year":"2022","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.13683\/j.wph.2022.03.007","article-title":"A randomised controled trial of the combination therapy of Longkui Yinxiao tablets and acitretin A capsules on moderate to severe psoriasis vulgaris with bood heat syndrome","volume":"43","author":"Zhao","year":"2022","journal-title":"World Clin. Drug"},{"key":"B27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fimmu.2018.00569","article-title":"MAPK phosphatase-1 deficiency exacerbates the severity of imiquimod-induced psoriasiform skin disease","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1136604\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T04:32:11Z","timestamp":1678681931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1136604\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":27,"alternative-id":["10.3389\/fphar.2023.1136604"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1136604","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"article-number":"1136604"}}